Share Share this content Opens in a new window Opens in a new window Opens in a new window Opens in a new window OPA's Response to Proposed Code of Ethics You may be interested in Letter to the Assistant Deputy Minister and Executive Officer Drugs and Devices Division Re: COVID-19 Vaccine Fee Increase May 9, 2022 Post category: Advocacy Become a Pharmacist October 28, 2020 Post category: Advocacy The Opioid and Pain Management in Pharmacies Program (OPMPP) Research Study December 18, 2023 Post category: Advocacy Representations to the Information and Privacy Commissioner of Ontario Re: request made under the Freedom of Information and Protection of Privacy Act for information from the Narcotics Monitoring System database May 9, 2022 Post category: Advocacy
Letter to the Assistant Deputy Minister and Executive Officer Drugs and Devices Division Re: COVID-19 Vaccine Fee Increase May 9, 2022 Post category: Advocacy
The Opioid and Pain Management in Pharmacies Program (OPMPP) Research Study December 18, 2023 Post category: Advocacy
Representations to the Information and Privacy Commissioner of Ontario Re: request made under the Freedom of Information and Protection of Privacy Act for information from the Narcotics Monitoring System database May 9, 2022 Post category: Advocacy
